{"id":2817,"date":"2025-02-05T12:23:36","date_gmt":"2025-02-05T09:23:36","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=2817"},"modified":"2025-09-07T12:46:40","modified_gmt":"2025-09-07T09:46:40","slug":"russian-biotech-company-generium-has-begun-clinical-trials-of-a-gene-therapy-for-duchenne-muscular-dystrophy","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/de\/russian-biotech-company-generium-has-begun-clinical-trials-of-a-gene-therapy-for-duchenne-muscular-dystrophy\/","title":{"rendered":"Russisches Biotechnologieunternehmen Generium hat mit klinischen Tests einer Gentherapie f\u00fcr die Muskeldystrophie Duchenne begonnen"},"content":{"rendered":"<p class=\"wp-block-paragraph\">An der Sirius University und dem russischen Biotech-Unternehmen Generium haben klinische Studien f\u00fcr eine Therapie der Duchenne-Muskeldystrophie begonnen. Bei einer Konferenz an der Staatlichen Universit\u00e4t Nowosibirsk legte Dmitry Kudlai, Mitglied der Russischen Akademie der Wissenschaften, seine Perspektiven dar.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Im russischen staatlichen Arzneimittelregister sind noch keine Informationen zu klinischen Studien f\u00fcr die Gentherapie der Muskeldystrophie Duchenne vorhanden. Als DMD Warrior werden wir diese Aussagen verfolgen.<\/p>","protected":false},"excerpt":{"rendered":"<p>Clinical studies for a therapy for Duchenne muscular dystrophy have begun at Sirius University and the Russian biotech business Generium. At a gathering at Novosibirsk State University, Dmitry Kudlai, a Member of the Russian Academy of Sciences, offered his perspectives. There is no clinical trial information for the Duchenne muscular dystrophy gene therapy in the [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2818,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[27],"tags":[137,242,61,241,414,135],"class_list":["post-2817","post","type-post","status-publish","format-standard","has-post-thumbnail","category-research","tag-clinical-trial","tag-clinical-trials","tag-gene-therapy","tag-generium","tag-gnr-097","tag-russia"],"subtitle":"Einem Artikel des Nachrichtenportals GXPNEWS zufolge wird das russische Biotech-Unternehmen Generium mit der Arbeit an einer Gentherapie zur Behandlung der Muskeldystrophie Duchenne beginnen.","_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/posts\/2817","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/comments?post=2817"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/posts\/2817\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/media\/2818"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/media?parent=2817"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/categories?post=2817"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/de\/wp-json\/wp\/v2\/tags?post=2817"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}